Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

This is a long-term follow-up (LTFU) study for patients who previously received a gene therapy called zamtocabtagene autoleucel in a Miltenyi Biomedicine-sponsored clinical trial. The goal is to monitor participants' long-term health and safety after receiving this therapy. **You may be eligible if:** - You received zamtocabtagene autoleucel as part of a previous Miltenyi Biomedicine clinical study - You have either completed that study or left it early - You are willing to provide written informed consent for this follow-up study **You may NOT be eligible if:** - There are no specific exclusion criteria for this study Talk to your doctor to see if this trial is right for you.